Disability Genetics iPS Japan

World’s 1st iPS Therapy for Spinal Cord Injuries Starts in Japan

Japan's Keio University said Friday it has started a clinical research to transplant neural progenitor cells derived from induced pluripotent stem, or iPS, cells into patients with spinal cord injuries, the first such attempt in the world.

From Jiji Press

January 14 2022

TOKYO – Japan’s Keio University said Friday it has started a clinical research to transplant neural progenitor cells derived from induced pluripotent stem, or iPS, cells into patients with spinal cord injuries, the first such attempt in the world.

A patient who received the transplant in December last year has developed no abnormalities, and the surgery was a success, according to the university.

At the same time, the university said it is still not possible to determine whether the patient’s motor functions have actually recovered.

Keio University professor Hideyuki Okano and his team have received iPS cells derived from a healthy person from Kyoto University and converted them into cells that are capable of developing into nerves.

About 2 million of such cells were injected into the damaged section of the patient’s spinal cord. The team will verify the safety and efficacy of the treatment while having the patient go through rehabilitation over a year.

0 comments on “World’s 1st iPS Therapy for Spinal Cord Injuries Starts in Japan

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: